Skip navigation
Home
News
Products
about IR-World
Team
Customers
Partner
Contact
DE
EN
Communicators
are winners!
Text der Meldung
More News
28.01.2020
Medigene AG: Adjustment of EBITDA guidance for fiscal year 2019 after receiving the assessment results from FREP
10.01.2020
Medigene AG: Positive final 2-year topline data in completed DC vaccine Phase I/II trial in AML patients
10.12.2019
Medigene AG: Interim 1-year clinical immune monitoring data from DC vaccine trial in AML presented at ASH 2019 Annual Meeting
13.11.2019
Medigene reports financial & business results for the first nine months of 2019
06.11.2019
Immune monitoring data from phase I/II clinical trial with DC vaccines in AML to be presented at ASH conference
05.11.2019
Medigene AG: Medigene to present on neoantigens as targets for TCR-T cell-based therapies at 2019 SITC Annual Meeting
30.10.2019
Medigene AG: Medigene participates at upcoming conferences
09.09.2019
Medigene AG: Medigene highlights its 'iM (inducible Medigene)-TCR' approach at CAR-TCR Summit 2019 in Boston, USA
06.09.2019
Medigene AG: Medigene participates at upcoming conferences
07.08.2019
Medigene AG: Medigene reports financial & business results for the first six months of 2019
First
Previous
6
7
8
9
10
11
12
Next
Last